These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21030360)

  • 1. Preservation of beta-cell function in type 2 diabetes.
    Nyalakonda K; Sharma T; Ismail-Beigi F
    Endocr Pract; 2010; 16(6):1038-55. PubMed ID: 21030360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choice of early treatment regimen and impact on β-cell preservation in type 2 diabetes.
    Mudaliar S
    Int J Clin Pract; 2013 Sep; 67(9):876-87. PubMed ID: 23952467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-cell failure in diabetes and preservation by clinical treatment.
    Wajchenberg BL
    Endocr Rev; 2007 Apr; 28(2):187-218. PubMed ID: 17353295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preservation of β-cell function: the key to diabetes prevention.
    DeFronzo RA; Abdul-Ghani MA
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2354-66. PubMed ID: 21697254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of beta-cell management in type 2 diabetes.
    Standl E
    Int J Clin Pract Suppl; 2007 Jun; (153):10-9. PubMed ID: 17594389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating second-line treatment options for type 2 diabetes: focus on secondary effects of GLP-1 agonists and DPP-4 inhibitors.
    Boland CL; Degeeter M; Nuzum DS; Tzefos M
    Ann Pharmacother; 2013 Apr; 47(4):490-505. PubMed ID: 23548652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta-cell rest?
    van Raalte DH; Verchere CB
    Diabetes Obes Metab; 2017 Sep; 19(9):1205-1213. PubMed ID: 28295962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early use of insulin for beta cell preservation.
    Kumar A
    J Assoc Physicians India; 2007 Jul; 55 Suppl():26-8. PubMed ID: 17927008
    [No Abstract]   [Full Text] [Related]  

  • 9. Liraglutide and the preservation of pancreatic β-cell function in early type 2 diabetes: the LIBRA trial.
    Retnakaran R; Kramer CK; Choi H; Swaminathan B; Zinman B
    Diabetes Care; 2014 Dec; 37(12):3270-8. PubMed ID: 25249651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can thiazolidinediones delay disease progression in type 2 diabetes?
    Leiter LA
    Curr Med Res Opin; 2006 Jun; 22(6):1193-201. PubMed ID: 16846552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors.
    Neumiller JJ
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S16-29. PubMed ID: 19801361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparisons between dipeptidyl peptidase-4 inhibitors and other classes of hypoglycemic drugs using two distinct biomarkers of pancreatic beta-cell function: A meta-analysis.
    Takahashi M; Shibasaki M; Echizen H; Kushiyama A
    PLoS One; 2020; 15(7):e0236603. PubMed ID: 32706828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-cell function and anti-diabetic pharmacotherapy.
    Del Prato S; Bianchi C; Marchetti P
    Diabetes Metab Res Rev; 2007 Oct; 23(7):518-27. PubMed ID: 17883249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycemic variability in patients with early type 2 diabetes: the impact of improvement in β-cell function.
    Kramer CK; Choi H; Zinman B; Retnakaran R
    Diabetes Care; 2014 Apr; 37(4):1116-23. PubMed ID: 24550219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet and prevention of type 2 diabetes mellitus: beyond weight loss and exercise.
    Palacios OM; Kramer M; Maki KC
    Expert Rev Endocrinol Metab; 2019 Jan; 14(1):1-12. PubMed ID: 30521416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the treatment of type 2 diabetes mellitus.
    Israili ZH
    Am J Ther; 2011; 18(2):117-52. PubMed ID: 19834322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementing insulin therapy to achieve glycemic control.
    Barnett AH
    Adv Ther; 2013 Jun; 30(6):557-76. PubMed ID: 23797471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes.
    Pratley RE; Salsali A
    Curr Med Res Opin; 2007 Apr; 23(4):919-31. PubMed ID: 17407649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current role of short-term intensive insulin strategies in newly diagnosed type 2 diabetes.
    Xu W; Weng J
    J Diabetes; 2013 Sep; 5(3):268-74. PubMed ID: 23551748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.